e-learning
resources
Virtual 2020
Pre-Congress Content
Interventional pulmonology: the pleura and bronchoscopic treatment of emphysema
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Human infection with zoonotic agent and COPD exacerbation in late course of endoscopic lung-volume reduction
A. Gonze (Bouge, Belgium), R. Frognier (Bouge, Belgium), A. Rezazadeh (Bouge, Belgium), A. Rosoux (Bouge, Belgium)
Source:
Virtual Congress 2020 – Interventional pulmonology: the pleura and bronchoscopic treatment of emphysema
Session:
Interventional pulmonology: the pleura and bronchoscopic treatment of emphysema
Session type:
E-poster session
Number:
879
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Gonze (Bouge, Belgium), R. Frognier (Bouge, Belgium), A. Rezazadeh (Bouge, Belgium), A. Rosoux (Bouge, Belgium). Human infection with zoonotic agent and COPD exacerbation in late course of endoscopic lung-volume reduction. 879
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 29: 1224-1238
Year: 2007
Clinical relevance of human bocavirus infection in acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2008 - New diagnostic methods in viral and atypical infections
Year: 2008
Treatment and prevention of acute respiratory viral infections in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Viral infections
Year: 2013
Bacterial profile of acute infectious exacerbations of chronic obstructive pulmonary disease requiring hospitalization in Greece
Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases
Year: 2011
The role of infections in acute exacerbations of COPD
Source: Annual Congress 2005 - Infection and acute exacerbation of COPD: what do we know?
Year: 2005
Respiratory viral infections in patients with exacerbation of chronic obstructive pulmonary disease and asthma in Korea
Source: Eur Respir J 2005; 26: Suppl. 49, 285s
Year: 2005
Chronic pulmonary diseases and the epidemiology of invasive pneumococcal infection
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012
Fungal VAP
Source: Eur Respir Mon 2011; 53: 122-137
Year: 2011
The role of chlamydia pneumoniae infection in acute purulent exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 221s
Year: 2002
Patterns of zoonotic exposure to chlamydia and their impact on acute and/or persistent pulmonary morbidity
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009
The role of respiratory virus infection in COPD exacerbations
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011
Impact of bacterial infections on airway diseases
Source: Eur Respir Rev 2005; 14: 62-68
Year: 2005
Impact of chronic bronchial infection on the lungs and beyond
Source: Eur Respir Monogr 2013; 60: 46-57
Year: 2013
Interferon inducer in treatment of acute respiratory viral infections in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014
Pseudomonas infection and home oxygen therapy can increase readmission in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2017 – Management of COPD
Year: 2017
Serological evidence of Legionella species infection in acute exacerbation of COPD
Source: Eur Respir J 2002; 19: 392-397
Year: 2002
Respiratory viral infections in Iranian patients with exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Year: 2010
Presence of bacterial infection influences the severity of symptoms in acute COPD exacerbations
Source: Eur Respir J 2002; 20: Suppl. 38, 261s
Year: 2002
A role of infectious factor in acute exacerbation of chronic obstructive bronchitis and late onset asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 141s
Year: 2001
Clinical relevance of respiratory pathogens in patients hospitalised with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept